speb/financial-data huggingface dataset:
Financial ratios for MMD — annual report dated 2025-05-31
Total revenue: 1207260
Net income: 861343
Capital expenditures: 0
Operating cash flow: 185598594
Net tangible assets: 295643042
Owner earnings: 861343
Return on net tangible assets (%): 0.2913456018356082
Buffett classification: The Gruesome
Stock price: 13.75
P/E ratio: 299.7847300668839
Shares outstanding: 18779453
Book value: 295643042
P/B ratio: 0.8734096260246165
Market cap (USD): 258217478.75
Debt to equity: 0.5861291333891768
COGS to revenue (%): 0
SG&A to revenue (%): 36.002269602239785
Free cash flow (dilution-adjusted): 185598594
Buyback yield (%): 59.83698963678306
Retained earnings: -90334142
Receivables turnover: 0.16346380902656668
Capitalized R&D asset: 0
FCF margin (%): 15373.539585507677
Revenue growth (%): -90.74669367099784
Rule of 40 score: 15282.79289183668
Financial ratios for MMD — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 295643042
Buffett classification: The Gruesome
Stock price: 13.75
Shares outstanding: 18779453
Book value: 295643042
P/B ratio: 0.8734096260246165
Market cap (USD): 258217478.75
Debt to equity: 0.5861291333891768
Buyback yield (%): 0
Retained earnings: -90334142
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSB.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.413533834586466
Shares outstanding: 1296960871
Market cap (USD): 1833298073.293233
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSB.AX — annual report dated 2022-06-30
Total revenue: 7042068.9655172415
Operating income: -55935862.06896552
Net income: -62997931.03448276
Capital expenditures: 108275.86206896552
Operating cash flow: -45366896.551724136
Depreciation & amortization: 3020689.6551724137
Net tangible assets: -56281379.31034483
Owner earnings: -60085517.24137931
Buffett classification: The Gruesome
Stock price: 0.39999999999999997
Shares outstanding: 1296960871
Book value: 342788965.5172414
P/B ratio: 1.5134219609933928
Market cap (USD): 518784348.4
Debt to equity: 0.215081562195701
Current ratio: 1.3594105853269225
Quick ratio: 1.3594105853269225
Interest coverage ratio: -4.691520129569644
COGS to revenue (%): 0
R&D to revenue (%): 321.3691117422388
SG&A to revenue (%): 567.6917050239938
Free cash flow (dilution-adjusted): -49344827.5862069
Buyback yield (%): 0
Retained earnings: -509597241.37931037
Receivables turnover: 2.3191006132182603
Capitalized R&D asset: 22631034.482758623
ROCI (R&D-adjusted, %): -9.203201654070538
FCF margin (%): -700.7149152874351
Rule of 40 score: -700.7149152874351
Financial ratios for MSB.AX — annual report dated 2023-06-30
Total revenue: 4967549.6688741725
Gross profit: 4967549.6688741725
Operating income: -45886754.966887414
Net income: -54231125.82781457
Capital expenditures: 174834.43708609272
Operating cash flow: -41900000
Depreciation & amortization: 2719867.549668874
Net tangible assets: -49897350.993377484
Owner earnings: -51686092.71523179
Buffett classification: The Gruesome
Stock price: 0.7152317880794702
Shares outstanding: 1296960871
Book value: 332343046.3576159
P/B ratio: 2.791175121612951
Market cap (USD): 927627642.834437
Debt to equity: 0.2321366656171912
Current ratio: 1.9450716973941213
Quick ratio: 1.9450716973941213
Interest coverage ratio: -3.5635157375025712
COGS to revenue (%): 0
R&D to revenue (%): 704.1194507399013
SG&A to revenue (%): 366.35115317957604
Free cash flow (dilution-adjusted): -44528476.82119205
Buyback yield (%): 0
Retained earnings: -543579470.1986755
Receivables turnover: 1.0718776793369535
Capitalized R&D asset: 50140276.547156885
ROCI (R&D-adjusted, %): -6.4665608305855455
FCF margin (%): -896.3871483802159
Revenue growth (%): -29.45894603988297
Rule of 40 score: -925.8460944200989
Financial ratios for MSB.AX — annual report dated 2024-06-30
Total revenue: 3934666.6666666665
Gross profit: 3934666.6666666665
Operating income: -38648000
Net income: -58637333.333333336
Capital expenditures: 180666.66666666666
Operating cash flow: -32305333.333333332
Depreciation & amortization: 3110666.6666666665
Net tangible assets: -63587333.333333336
Owner earnings: -55707333.333333336
Buffett classification: The Gruesome
Stock price: 0.66
Shares outstanding: 1296960871
Book value: 320236666.6666667
P/B ratio: 2.6730048865734717
Market cap (USD): 855994174.86
Debt to equity: 0.24757314902520008
Current ratio: 1.1804950643747525
Quick ratio: 1.1804950643747525
Interest coverage ratio: -2.806273598605867
COGS to revenue (%): 0
R&D to revenue (%): 672.924432395798
SG&A to revenue (%): 423.246357167062
Free cash flow (dilution-adjusted): -36439333.333333336
Buyback yield (%): 0
Retained earnings: -605840666.6666666
Receivables turnover: 0.2816914852997327
Capitalized R&D asset: 57380488.61992844
ROCI (R&D-adjusted, %): -8.84173448285657
Rosenberg metric: -0.02952994042209433
FCF margin (%): -926.1097932904102
Revenue growth (%): -20.792605430387066
Rule of 40 score: -946.9023987207972
Financial ratios for MSB.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8068965517241379
Shares outstanding: 1296960871
Market cap (USD): 1046513254.5310345
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSB.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -70569565.2173913
Buffett classification: The Gruesome
Stock price: 1.9254658385093166
Shares outstanding: 1296960871
Book value: 286498136.6459627
P/B ratio: 8.7164750187529
Market cap (USD): 2497253850.9937887
Debt to equity: 0.2734042691572252
Current ratio: 0.9577869415807561
Quick ratio: 0.6252233676975946
Buyback yield (%): 0
Retained earnings: -594220496.8944099
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSB.AX — quarterly report dated 2025-03-31
Capital expenditures: 47169.811320754714
Buffett classification: The Gruesome
Stock price: 1.2327044025157232
Shares outstanding: 1296960871
Market cap (USD): 1598769375.572327
Free cash flow (dilution-adjusted): -8055345.911949685
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSB.AX — annual report dated 2025-06-30
Total revenue: 11240522.875816993
Gross profit: 7887581.699346405
Operating income: -40812418.30065359
Net income: -66759477.12418301
Capital expenditures: 444444.44444444444
Operating cash flow: -32649673.20261438
Depreciation & amortization: 4183006.535947712
Net tangible assets: 16742483.660130719
Owner earnings: -63020915.032679744
Return on net tangible assets (%): -376.4131792629607
Buffett classification: The Gruesome
Stock price: 1.0784313725490196
Shares outstanding: 1296960871
Book value: 390484967.3202615
P/B ratio: 3.5819132855574263
Market cap (USD): 1398683292.254902
Debt to equity: 0.21450952561085423
Current ratio: 1.9912108042796173
Quick ratio: 1.7744431235749225
Interest coverage ratio: -2.8705465912747665
COGS to revenue (%): 29.829049889522036
R&D to revenue (%): 202.38981276892662
SG&A to revenue (%): 228.56727526456564
Free cash flow (dilution-adjusted): -47563398.69281046
Buyback yield (%): 0
Retained earnings: -660720915.0326797
Inventory turnover: 0.23060325451766608
Receivables turnover: 1.1568680209874882
Capitalized R&D asset: 52032056.07237155
ROCI (R&D-adjusted, %): -9.266566401335554
Rosenberg metric: 0.14929430327876947
FCF margin (%): -423.142225840214
Revenue growth (%): 185.67916492249225
Rule of 40 score: -237.46306091772175
Financial ratios for MSB.AX — quarterly report dated 2025-06-30
Capital expenditures: 326143.7908496732
Net tangible assets: 16742483.660130719
Buffett classification: The Gruesome
Stock price: 1.0784313725490196
Shares outstanding: 1296960871
Book value: 390484967.3202615
P/B ratio: 3.5819132855574263
Market cap (USD): 1398683292.254902
Debt to equity: 0.21450952561085423
Current ratio: 1.9912108042796173
Quick ratio: 1.7744431235749225
Free cash flow (dilution-adjusted): -11186274.509803921
Buyback yield (%): 0
Retained earnings: -660720915.0326797
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSB.AX — quarterly report dated 2025-09-30
Capital expenditures: 229605.26315789475
Buffett classification: The Gruesome
Stock price: 1.5592105263157896
Shares outstanding: 1296960871
Market cap (USD): 2022235042.2828948
Free cash flow (dilution-adjusted): -10036184.210526315
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSB.AX — quarterly report dated 2025-12-31
Capital expenditures: 48993.288590604025
Net tangible assets: 3948993.288590604
Buffett classification: The Gruesome
Stock price: 1.8255033557046982
Shares outstanding: 1296960871
Book value: 385693959.73154366
P/B ratio: 6.138562356216634
Market cap (USD): 2367606422.228188
Debt to equity: 0.23516228048805948
Current ratio: 1.5810461548071744
Quick ratio: 1.411887341979714
Free cash flow (dilution-adjusted): -10450335.570469799
Buyback yield (%): 0
Retained earnings: -705412751.6778524
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MUSA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 194.87
Shares outstanding: 18470685
Market cap (USD): 3599382385.9500003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MUSA — annual report dated 2022-12-31
Total revenue: 23446100000
Gross profit: 2399900000
Operating income: 967800000
Net income: 672900000
Capital expenditures: 305300000
Operating cash flow: 994700000
Depreciation & amortization: 220400000
Net tangible assets: 172300000
Owner earnings: 588000000
Return on net tangible assets (%): 341.2652350551364
Capex to operating income (%): 31.54577392023145
Buffett classification: The Good
Stock price: 274.81
P/E ratio: 7.543362973473028
Shares outstanding: 18470685
Book value: 640700000
P/B ratio: 7.922473770641486
Market cap (USD): 5075928944.85
Debt to equity: 3.545497112533167
Current ratio: 0.8508546007960665
Quick ratio: 0.4772886911730274
Effective tax rate (%): 23.86286490156144
Interest coverage ratio: 11.345838218053927
COGS to revenue (%): 89.76418252929058
SG&A to revenue (%): 0.9916361356472931
Free cash flow (dilution-adjusted): 689400000
Buyback yield (%): 15.886747209457441
Retained earnings: 2755100000
Inventory turnover: 65.95487308053902
Receivables turnover: 83.23074192403266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.60538390945243
FCF margin (%): 2.9403610835064256
Rule of 40 score: 2.9403610835064256
Financial ratios for MUSA — annual report dated 2023-12-31
Total revenue: 21529400000
Gross profit: 2313800000
Operating income: 826800000
Net income: 556800000
Capital expenditures: 335600000
Operating cash flow: 784000000
Depreciation & amortization: 228700000
Net tangible assets: 361100000
Owner earnings: 449900000
Return on net tangible assets (%): 124.5915258931044
Capex to operating income (%): 40.59022738268021
Buffett classification: The Good
Stock price: 352.31
P/E ratio: 11.687153434536638
Shares outstanding: 18470685
Book value: 828900000
P/B ratio: 7.850653917661962
Market cap (USD): 6507407032.35
Debt to equity: 2.7411026661840996
Current ratio: 0.9469523373052245
Quick ratio: 0.5560265811182401
Effective tax rate (%): 24.18300653594771
Interest coverage ratio: 8.393908629441624
COGS to revenue (%): 89.25283565728725
SG&A to revenue (%): 1.1170771131568924
Free cash flow (dilution-adjusted): 448400000
Buyback yield (%): 5.120319020211534
Retained earnings: 3278100000
Inventory turnover: 56.31770222743259
Receivables turnover: 63.94238194238194
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.845643584345165
FCF margin (%): 2.0827333785428297
Revenue growth (%): -8.174920349226523
Rule of 40 score: -6.092186970683693
Financial ratios for MUSA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 488.41
Shares outstanding: 18470685
Market cap (USD): 9021267260.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MUSA — annual report dated 2024-12-31
Total revenue: 20244300000
Gross profit: 2306800000
Operating income: 755600000
Net income: 502500000
Capital expenditures: 458100000
Operating cash flow: 847600000
Depreciation & amortization: 248000000
Net tangible assets: 372600000
Owner earnings: 292400000
Return on net tangible assets (%): 78.47557702630166
Capex to operating income (%): 60.62731604023293
Buffett classification: The Good
Stock price: 497.7
P/E ratio: 18.29424860597015
Shares outstanding: 18470685
Book value: 840100000
P/B ratio: 10.942578174622069
Market cap (USD): 9192859924.5
Debt to equity: 2.819188191881919
Current ratio: 0.789218271969617
Quick ratio: 0.3655448887013398
Effective tax rate (%): 22.882136279926335
Interest coverage ratio: 7.781668383110196
COGS to revenue (%): 88.60518763306214
SG&A to revenue (%): 1.162796441467475
Free cash flow (dilution-adjusted): 389500000
Buyback yield (%): 4.848327981286429
Retained earnings: 3743400000
Inventory turnover: 44.665089641434264
Receivables turnover: 75.39776536312849
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.025683835601193
FCF margin (%): 1.9239983600322066
Revenue growth (%): -5.969046977621299
Rule of 40 score: -4.045048617589092
Financial ratios for MUSA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 497.7
Shares outstanding: 18470685
Market cap (USD): 9192859924.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MUSA — quarterly report dated 2025-03-31
Total revenue: 5041000000
Gross profit: 483600000
Operating income: 88300000
Net income: 53200000
Capital expenditures: 87800000
Operating cash flow: 128500000
Depreciation & amortization: 68200000
Net tangible assets: 252100000
Owner earnings: 33600000
Return on net tangible assets (%): 13.328044426814756
Capex to operating income (%): 99.43374858437146
Buffett classification: The Gruesome
Stock price: 466.53
P/E ratio: 40.49402571921992
Shares outstanding: 18470685
Book value: 719600000
P/B ratio: 11.974886983115619
Market cap (USD): 8617128673.05
Debt to equity: 3.4521956642579212
Current ratio: 0.8033191298497421
Quick ratio: 0.3947073334828437
Effective tax rate (%): 14.054927302100161
Interest coverage ratio: 3.4763779527559056
COGS to revenue (%): 80.17853600476096
SG&A to revenue (%): 1.192223765125967
Free cash flow (dilution-adjusted): 40700000
Buyback yield (%): 1.740719045650598
Retained earnings: 3786700000
Inventory turnover: 11.09165751920966
Receivables turnover: 18.52627710400588
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4455091810452267
FCF margin (%): 0.8073794881967864
Rule of 40 score: 0.8073794881967864
Financial ratios for MUSA — quarterly report dated 2025-06-30
Total revenue: 5543300000
Gross profit: 612100000
Operating income: 219200000
Net income: 145600000
Capital expenditures: 118000000
Operating cash flow: 255100000
Depreciation & amortization: 66000000
Net tangible assets: 172200000
Owner earnings: 93600000
Return on net tangible assets (%): 54.35540069686411
Capex to operating income (%): 53.83211678832117
Buffett classification: The Good
Stock price: 404.41
P/E ratio: 37.57409316322938
Shares outstanding: 18470685
Book value: 646100000
P/B ratio: 11.56125943483981
Market cap (USD): 7469729720.85
Debt to equity: 4.00804828973843
Current ratio: 0.7954103063210737
Quick ratio: 0.38817744083597994
Effective tax rate (%): 24.363636363636363
Interest coverage ratio: 7.884892086330935
COGS to revenue (%): 79.24701892374578
SG&A to revenue (%): 0.9182256056861438
Free cash flow (dilution-adjusted): 137100000
Buyback yield (%): 2.8622186878224976
Retained earnings: 3922400000
Inventory turnover: 11.051320754716981
Receivables turnover: 18.708403644954437
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.011903129371109
FCF margin (%): 2.473256002742049
Revenue growth (%): 9.964292799047808
Rule of 40 score: 12.437548801789857
Financial ratios for MUSA — quarterly report dated 2025-09-30
Total revenue: 5660900000
Gross profit: 626300000
Operating income: 214300000
Net income: 129900000
Capital expenditures: 117100000
Operating cash flow: 184800000
Depreciation & amortization: 69900000
Net tangible assets: 78600000
Owner earnings: 82700000
Return on net tangible assets (%): 105.21628498727735
Capex to operating income (%): 54.64302379841344
Buffett classification: The Good
Stock price: 386.52
P/E ratio: 21.7197723340432
Shares outstanding: 18470685
Book value: 546000000
P/B ratio: 13.075621183516482
Market cap (USD): 7139289166.2
Debt to equity: 5.043040293040293
Current ratio: 0.8118485428632206
Quick ratio: 0.4000212720697724
Effective tax rate (%): 25.08650519031142
Interest coverage ratio: 7.364261168384879
COGS to revenue (%): 79.204720097511
SG&A to revenue (%): 0.9768764684060839
Free cash flow (dilution-adjusted): 67700000
Buyback yield (%): 3.0703336830475054
Retained earnings: 4042200000
Inventory turnover: 11.579803719008265
Receivables turnover: 18.61525813877014
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.735467294722193
FCF margin (%): 1.195922909784663
Revenue growth (%): 2.1214799848465713
Rule of 40 score: 3.3174028946312344
Financial ratios for MUSA — annual report dated 2025-12-31
Total revenue: 19384000000
Gross profit: 2359400000
Operating income: 739200000
Net income: 470600000
Capital expenditures: 439600000
Operating cash flow: 813900000
Depreciation & amortization: 276800000
Net tangible assets: 156200000
Owner earnings: 307800000
Return on net tangible assets (%): 197.0550576184379
Capex to operating income (%): 59.46969696969697
Buffett classification: The Good
Stock price: 402.41
P/E ratio: 15.794280388546538
Shares outstanding: 18470685
Book value: 623500000
P/B ratio: 11.921071934001604
Market cap (USD): 7432788350.85
Debt to equity: 4.3993584603047315
Current ratio: 0.8048649230438059
Quick ratio: 0.3603487245721666
Effective tax rate (%): 22.751149047931712
Interest coverage ratio: 6.66546438232642
COGS to revenue (%): 87.82810565414775
SG&A to revenue (%): 1.19428394552208
Free cash flow (dilution-adjusted): 374300000
Buyback yield (%): 8.743690380013023
Retained earnings: 4172300000
Inventory turnover: 41.22179176755448
Receivables turnover: 70.18102824040551
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.469539336792476
FCF margin (%): 1.930973999174577
Revenue growth (%): -4.249591242967156
Rule of 40 score: -2.3186172437925796
Financial ratios for MUSA — quarterly report dated 2025-12-31
Total revenue: 4743600000
Gross profit: 637400000
Operating income: 217400000
Net income: 141900000
Capital expenditures: 116700000
Operating cash flow: 245500000
Depreciation & amortization: 72700000
Net tangible assets: 156200000
Owner earnings: 97900000
Return on net tangible assets (%): 62.676056338028175
Capex to operating income (%): 53.67985280588776
Buffett classification: The Good
Stock price: 402.41
P/E ratio: 15.794280388546538
Shares outstanding: 18470685
Book value: 623500000
P/B ratio: 11.921071934001604
Market cap (USD): 7432788350.85
Debt to equity: 4.3993584603047315
Current ratio: 0.8048649230438059
Quick ratio: 0.3603487245721666
Effective tax rate (%): 21.775082690187432
Interest coverage ratio: 7.601398601398602
COGS to revenue (%): 86.5629479720044
SG&A to revenue (%): 1.3744835146302385
Free cash flow (dilution-adjusted): 128800000
Buyback yield (%): 0.900065989264304
Retained earnings: 4172300000
Inventory turnover: 9.942372881355933
Receivables turnover: 17.174511223750905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.726025232438697
FCF margin (%): 2.715237372459735
Revenue growth (%): -16.204137151336358
Rule of 40 score: -13.488899778876622
Financial ratios for NC6.AX — annual report dated 2021-06-30
Capital expenditures: 54250.37593984962
Buffett classification: The Gruesome
Stock price: 0.06766917293233082
Shares outstanding: 408954364
Market cap (USD): 27673603.578947365
Buyback yield (%): 0.6485591901181208
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NC6.AX — annual report dated 2022-06-30
Operating income: -1226094.4827586208
Net income: -1080347.5862068967
Capital expenditures: 3691.034482758621
Depreciation & amortization: 44830.34482758621
Net tangible assets: 1191944.1379310344
Owner earnings: -1039208.2758620691
Return on net tangible assets (%): -87.18598823481084
Buffett classification: The Gruesome
Stock price: 0.048275862068965524
Shares outstanding: 408954364
Book value: 1205737.2413793104
P/B ratio: 16.373902863264657
Market cap (USD): 19742624.46896552
Debt to equity: 0.021788357845450402
Current ratio: 9.193312728294464
Quick ratio: 9.193312728294464
Interest coverage ratio: -601.026707234618
Free cash flow (dilution-adjusted): -957005.5172413794
Buyback yield (%): 0
Retained earnings: -5725243.448275862
Capitalized R&D asset: 309078.6206896552
ROCI (R&D-adjusted, %): -67.33769394072252
Rule of 40 score: 0
Financial ratios for NC6.AX — annual report dated 2023-06-30
Total revenue: 25232.450331125827
Gross profit: 25232.450331125827
Operating income: -1022728.4768211921
Net income: -891162.9139072847
Capital expenditures: 0
Depreciation & amortization: 24350.331125827815
Net tangible assets: 299094.03973509936
Owner earnings: -866812.5827814569
Return on net tangible assets (%): -289.8127236334006
Buffett classification: The Gruesome
Stock price: 0.033112582781456956
Shares outstanding: 408954364
Book value: 299094.03973509936
P/B ratio: 45.2751758068516
Market cap (USD): 13541535.23178808
Debt to equity: 0.02550527863393205
Current ratio: 3.3024514608548174
Quick ratio: 3.3024514608548174
Interest coverage ratio: -1299.9326599326598
COGS to revenue (%): 0
R&D to revenue (%): 928.7813968137319
SG&A to revenue (%): 1883.6014802761085
Free cash flow (dilution-adjusted): -669821.1920529802
Buyback yield (%): 0
Retained earnings: -6388913.245033112
Receivables turnover: 1.8629473890084098
Capitalized R&D asset: 441436.98049783055
ROCI (R&D-adjusted, %): -130.92206189043634
FCF margin (%): -2654.602241410987
Rule of 40 score: -2654.602241410987
Financial ratios for NC6.AX — annual report dated 2024-06-30
Total revenue: 8334
Gross profit: 8334
Operating income: -964849.3333333334
Net income: -771035.3333333334
Capital expenditures: 0
Depreciation & amortization: 23941.333333333332
Net tangible assets: -149128
Owner earnings: -747094
Buffett classification: The Gruesome
Stock price: 0.02
Shares outstanding: 408954364
Book value: -149128.00000000003
Market cap (USD): 8179087.28
Debt to equity: -0.1901274967365842
Current ratio: 0.3992157081712814
Quick ratio: 0.3992157081712814
Interest coverage ratio: -66.14900132547191
COGS to revenue (%): 0
R&D to revenue (%): 2891.392688584913
SG&A to revenue (%): 4800.519958403328
Free cash flow (dilution-adjusted): -600635.3333333334
Buyback yield (%): 0.6116574904675671
Retained earnings: -7202541.333333333
Receivables turnover: 1.1802303625377644
Capitalized R&D asset: 499981.9956002132
ROCI (R&D-adjusted, %): -280.8427084638744
Rosenberg metric: -0.07210642175909572
FCF margin (%): -7207.0474362051045
Revenue growth (%): -66.971103120653
Rule of 40 score: -7274.018539325758
Financial ratios for OD6.AX — annual report dated 2022-06-30
Operating income: -923902.0689655172
Net income: -923585.5172413794
Capital expenditures: 113737.93103448277
Depreciation & amortization: 1253.7931034482758
Net tangible assets: 6015402.75862069
Owner earnings: -1036069.6551724139
Return on net tangible assets (%): -17.223612395489557
Buffett classification: The Gruesome
Stock price: 0.11034482758620691
Shares outstanding: 291375932
Book value: 6015402.75862069
P/B ratio: 5.344916752786583
Market cap (USD): 32151826.97931035
Debt to equity: 0
Current ratio: 12.7161691746432
Quick ratio: 12.7161691746432
Free cash flow (dilution-adjusted): -792454.4827586208
Buyback yield (%): 0.1474426858289723
Retained earnings: -943775.1724137932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.358939476520847
Rule of 40 score: 0
Financial ratios for OD6.AX — annual report dated 2023-06-30
Operating income: -981808.6092715232
Net income: -898543.0463576159
Capital expenditures: 52778.14569536424
Depreciation & amortization: 16380.132450331126
Net tangible assets: 5076521.19205298
Owner earnings: -934941.059602649
Return on net tangible assets (%): -18.416963590465233
Buffett classification: The Gruesome
Stock price: 0.12582781456953643
Shares outstanding: 291375932
Book value: 5076521.19205298
P/B ratio: 7.222110448217199
Market cap (USD): 36663196.74172185
Debt to equity: 0
Current ratio: 3.9520682237831455
Quick ratio: 3.9520682237831455
Free cash flow (dilution-adjusted): -2976552.317880795
Buyback yield (%): 0.6267902008713898
Retained earnings: -1804817.2185430464
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.34018537750796
Rule of 40 score: 0
Financial ratios for OPFI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.22
Shares outstanding: 85393248
Market cap (USD): 360359506.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPFI — annual report dated 2022-12-31
Total revenue: 452859000
Gross profit: 357721000
Operating income: 231188000
Net income: 7098000
Capital expenditures: 13250000
Operating cash flow: 243297000
Depreciation & amortization: 13581000
Net tangible assets: -494000
Owner earnings: 7429000
Return on net tangible assets (%): -1503.8461538461538
Capex to operating income (%): 5.731266328702182
Buffett classification: The Great
Stock price: 1.91
P/E ratio: 22.978459239222314
Shares outstanding: 85393248
Book value: 159150000
P/B ratio: 1.0248262876531573
Market cap (USD): 163101103.68
Debt to equity: 2.2847502356267673
Current ratio: 9.244858017867822
Quick ratio: 9.244858017867822
Effective tax rate (%): -9.043421482206988
Interest coverage ratio: 7.050564196401342
COGS to revenue (%): 21.0083050132602
SG&A to revenue (%): 19.330520095658912
Free cash flow (dilution-adjusted): 226693000
Buyback yield (%): 1.508266924316131
Retained earnings: -63546000
Receivables turnover: 0.984606654360687
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 44.06468238236101
FCF margin (%): 50.058185881256634
Rule of 40 score: 50.058185881256634
Financial ratios for OPFI — annual report dated 2023-12-31
Total revenue: 508949000
Gross profit: 401519000
Operating income: 277774000
Net income: 39479000
Capital expenditures: 8991000
Operating cash flow: 296146000
Depreciation & amortization: 12735000
Net tangible assets: 10440000
Owner earnings: 43223000
Return on net tangible assets (%): 414.01340996168585
Capex to operating income (%): 3.2368040205346795
Buffett classification: The Great
Stock price: 4.76
P/E ratio: 10.295900617543504
Shares outstanding: 85393248
Book value: 194029000
P/B ratio: 2.0949026201237957
Market cap (USD): 406471860.47999996
Debt to equity: 1.7996124290698814
Current ratio: 10.476890797116935
Quick ratio: 10.476890797116935
Effective tax rate (%): 5.575221238938053
COGS to revenue (%): 21.10820534081018
SG&A to revenue (%): 17.027835794942124
Free cash flow (dilution-adjusted): 283088000
Buyback yield (%): 0
Retained earnings: -63591000
Receivables turnover: 1.0937283757473126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 50.497936626247565
FCF margin (%): 55.62207608227936
Revenue growth (%): 12.385753623092398
Rule of 40 score: 68.00782970537176
Financial ratios for OPFI — annual report dated 2024-12-31
Total revenue: 525963000
Gross profit: 420780000
Operating income: 298979000
Net income: 83837000
Capital expenditures: 13010000
Operating cash flow: 323806000
Depreciation & amortization: 9621000
Net tangible assets: 32774000
Owner earnings: 80448000
Return on net tangible assets (%): 245.46286690669433
Capex to operating income (%): 4.351476190635463
Buffett classification: The Great
Stock price: 7.43
P/E ratio: 7.5679214742893945
Shares outstanding: 85393248
Book value: 234213000
P/B ratio: 2.708952247057166
Market cap (USD): 634471832.64
Debt to equity: 1.4177351385277503
Current ratio: 9.43208802969999
Quick ratio: 9.43208802969999
Effective tax rate (%): 4.786944078499069
COGS to revenue (%): 19.998174776552723
SG&A to revenue (%): 17.085802613491825
Free cash flow (dilution-adjusted): 305526000
Buyback yield (%): 0.5596781160834986
Retained earnings: -55127000
Receivables turnover: 1.1055867589314992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 51.42636482946404
FCF margin (%): 58.08887697423582
Revenue growth (%): 3.342967566494875
Rule of 40 score: 61.4318445407307
Financial ratios for OPFI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.43
Shares outstanding: 85393248
Market cap (USD): 634471832.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OPFI — quarterly report dated 2025-03-31
Total revenue: 140268000
Gross profit: 116243000
Operating income: 91950000
Net income: 20390000
Capital expenditures: 4390000
Operating cash flow: 83740000
Depreciation & amortization: 1760000
Net tangible assets: 22550000
Owner earnings: 17760000
Return on net tangible assets (%): 78.75831485587584
Capex to operating income (%): 4.774333877107123
Buffett classification: The Great
Stock price: 9.02
P/E ratio: 9.443932037273173
Shares outstanding: 85393248
Book value: 236764000
P/B ratio: 3.253227251440253
Market cap (USD): 770247096.9599999
Debt to equity: 1.2706281360341944
Current ratio: 8.37418255923594
Quick ratio: 8.37418255923594
Effective tax rate (%): 7.490585726600426
COGS to revenue (%): 17.127926540622237
SG&A to revenue (%): 12.791228220264067
Free cash flow (dilution-adjusted): 78089000
Buyback yield (%): 0
Retained earnings: -72168000
Receivables turnover: 0.3050179616759592
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.01029394864866
FCF margin (%): 55.67128639461602
Rule of 40 score: 55.67128639461602
Financial ratios for OPFI — quarterly report dated 2025-06-30
Total revenue: 142443000
Gross profit: 115050000
Operating income: 87005000
Net income: 11480000
Capital expenditures: 4640000
Operating cash flow: 95617000
Depreciation & amortization: 1502000
Net tangible assets: 13351000
Owner earnings: 8342000
Return on net tangible assets (%): 62.48221107033181
Capex to operating income (%): 5.333026837538073
Buffett classification: The Great
Stock price: 13.99
P/E ratio: 26.015930738675962
Shares outstanding: 85393248
Book value: 217705000
P/B ratio: 5.487478650099907
Market cap (USD): 1194651539.52
Debt to equity: 1.461978365218989
Current ratio: 8.516869276098024
Quick ratio: 8.516869276098024
Effective tax rate (%): 9.634760705289674
COGS to revenue (%): 19.230850234830772
SG&A to revenue (%): 15.188531552972066
Free cash flow (dilution-adjusted): 85886000
Buyback yield (%): 0
Retained earnings: -91531000
Receivables turnover: 0.2874587558649917
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.3571659593006
FCF margin (%): 60.294995191058874
Revenue growth (%): 1.5506031311489434
Rule of 40 score: 61.84559832220782
Financial ratios for OPFI — quarterly report dated 2025-09-30
Total revenue: 155089000
Gross profit: 130497000
Operating income: 98977000
Net income: 75933000
Capital expenditures: 5186000
Operating cash flow: 105124000
Depreciation & amortization: 1133000
Net tangible assets: 49423000
Owner earnings: 71880000
Return on net tangible assets (%): 145.438358658924
Capex to operating income (%): 5.2396011194519945
Buffett classification: The Great
Stock price: 11.33
P/E ratio: 8.974754875467287
Shares outstanding: 85393248
Book value: 277254000
P/B ratio: 3.4895997887857346
Market cap (USD): 967505499.84
Debt to equity: 1.2001846682103774
Current ratio: 8.538229515455074
Quick ratio: 8.538229515455074
Effective tax rate (%): 6.922039715616572
COGS to revenue (%): 15.856701635834908
SG&A to revenue (%): 16.47054272063138
Free cash flow (dilution-adjusted): 98010000
Buyback yield (%): 0.7600990383223825
Retained earnings: -49795000
Receivables turnover: 0.28619539803542726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.266194795639947
FCF margin (%): 63.19597134548549
Revenue growth (%): 8.87793713976819
Rule of 40 score: 72.07390848525368
Financial ratios for OPFI — annual report dated 2025-12-31
Total revenue: 597050000
Gross profit: 496988000
Operating income: 382546000
Net income: 146247000
Capital expenditures: 19113000
Operating cash flow: 401305000
Depreciation & amortization: 5159000
Net tangible assets: 58484000
Owner earnings: 132293000
Return on net tangible assets (%): 226.20374803365024
Capex to operating income (%): 4.996261887459285
Buffett classification: The Great
Stock price: 10.46
P/E ratio: 6.107567157480154
Shares outstanding: 85393248
Book value: 308876000
P/B ratio: 2.8918186394540206
Market cap (USD): 893213374.08
Debt to equity: 1.0773805669589092
Current ratio: 7.437591588937219
Quick ratio: 7.437591588937219
Effective tax rate (%): 6.331181308123895
COGS to revenue (%): 16.75940038522737
SG&A to revenue (%): 15.360522569299054
Free cash flow (dilution-adjusted): 372204000
Buyback yield (%): 1.7372108893893734
Retained earnings: -33505000
Receivables turnover: 1.093025725144443
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 57.25810797056763
FCF margin (%): 62.34050749518466
Revenue growth (%): 13.515589499641608
Rule of 40 score: 75.85609699482627
Financial ratios for OPFI — quarterly report dated 2025-12-31
Total revenue: 159250000
Gross profit: 135198000
Operating income: 104614000
Net income: 38444000
Capital expenditures: 4897000
Operating cash flow: 116824000
Depreciation & amortization: 764000
Net tangible assets: 58484000
Owner earnings: 34311000
Return on net tangible assets (%): 58.667327816154845
Capex to operating income (%): 4.681017837000784
Buffett classification: The Great
Stock price: 10.46
P/E ratio: 6.107567157480154
Shares outstanding: 85393248
Book value: 308876000
P/B ratio: 2.8918186394540206
Market cap (USD): 893213374.08
Debt to equity: 1.0773805669589092
Current ratio: 7.437591588937219
Quick ratio: 7.437591588937219
Effective tax rate (%): 3.4240209008465845
COGS to revenue (%): 15.103296703296703
SG&A to revenue (%): 15.78712715855573
Free cash flow (dilution-adjusted): 110219000
Buyback yield (%): 0.9138913765602537
Retained earnings: -33505000
Receivables turnover: 0.2915406527581485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.658246870266485
FCF margin (%): 69.21130298273155
Revenue growth (%): 2.68297558176273
Rule of 40 score: 71.89427856449429
Financial ratios for PAVS — annual report dated 2022-03-31
Total revenue: 20758645
Gross profit: 257260
Operating income: -11165032
Net income: -49190610
Capital expenditures: 273650
Operating cash flow: -10498509
Depreciation & amortization: 34610
Net tangible assets: 57939752
Owner earnings: -49429650
Return on net tangible assets (%): -85.31215321736275
Buffett classification: The Gruesome
Stock price: 705600
Shares outstanding: 856851
Book value: 77414604
P/B ratio: 7809.819263559109
Market cap (USD): 604594065600
Debt to equity: 0.029301448083361634
Current ratio: 3.154837582062793
Quick ratio: 3.0773430566336026
COGS to revenue (%): 98.76070909252506
R&D to revenue (%): 8.112711595578613
SG&A to revenue (%): 55.02426579384155
Free cash flow (dilution-adjusted): -11858390
Buyback yield (%): 0
Retained earnings: 12285281
Inventory turnover: 14.753857513272177
Receivables turnover: 0.71010354129106
Capitalized R&D asset: 1684089
ROCI (R&D-adjusted, %): -12.370620123049797
FCF margin (%): -57.125067652537055
Rule of 40 score: -57.125067652537055
Financial ratios for PAVS — annual report dated 2023-03-31
Total revenue: 0
Gross profit: 0
Operating income: -4002589
Net income: -71738874
Capital expenditures: 65545
Operating cash flow: -20705496
Depreciation & amortization: 31667
Net tangible assets: 7706710
Owner earnings: -71772752
Return on net tangible assets (%): -931.3020990798927
Buffett classification: The Gruesome
Stock price: 614400
Shares outstanding: 856851
Book value: 13873071
P/B ratio: 37947.564342458856
Market cap (USD): 526449254400
Debt to equity: 0.16154144961847308
Current ratio: 0.46704216917438096
Quick ratio: 0.45105315791789635
Free cash flow (dilution-adjusted): -20705496
Buyback yield (%): 0
Retained earnings: -59453593
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 2525457.63
ROCI (R&D-adjusted, %): -20.279257649652173
Rosenberg metric: -0.15275914752723876
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for PAVS — annual report dated 2024-03-31
Total revenue: 0
Gross profit: 0
Operating income: -2462095
Net income: -9927324
Capital expenditures: 0
Operating cash flow: -13105978
Depreciation & amortization: 380000
Net tangible assets: 716107
Owner earnings: -9547324
Return on net tangible assets (%): -1333.2259005986537
Buffett classification: The Gruesome
Stock price: 217200
Shares outstanding: 856851
Book value: 5168445
P/B ratio: 36008.51652673096
Market cap (USD): 186108037200
Debt to equity: 0.43533403180260216
Current ratio: 1.1137838470133936
Quick ratio: 1.1137838470133936
Interest coverage ratio: -62.86146500880844
Free cash flow (dilution-adjusted): -13105978
Buyback yield (%): 0
Retained earnings: -61957019
Receivables turnover: 0
Capitalized R&D asset: 1491818.4300000002
ROCI (R&D-adjusted, %): -52.3877777008589
Rosenberg metric: 0
Rule of 40 score: 0
Financial ratios for PAVS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 25315593
Buffett classification: The Gruesome
Stock price: 57600
Shares outstanding: 856851
Book value: 29990112
P/B ratio: 1645.6963415141631
Market cap (USD): 49354617600
Debt to equity: 0.074933364703673
Current ratio: 8.743457911681086
Quick ratio: 8.743457911681086
Buyback yield (%): 0
Retained earnings: -64135066
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PAVS — annual report dated 2025-03-31
Total revenue: 71542
Gross profit: 9016
Operating income: -2299042
Net income: -7893248
Capital expenditures: 0
Operating cash flow: -2669456
Depreciation & amortization: 380000
Net tangible assets: -3995127
Owner earnings: -7513248
Buffett classification: The Gruesome
Stock price: 163200
Shares outstanding: 856851
Book value: 29002597
P/B ratio: 4821.5710889614475
Market cap (USD): 139838083200
Debt to equity: 0.08108198034817365
Current ratio: 1.1221548890955473
Quick ratio: 1.0201257596449433
Interest coverage ratio: -8.779862060537551
COGS to revenue (%): 87.39761259120516
SG&A to revenue (%): 3226.1580609991333
Free cash flow (dilution-adjusted): -2669456
Buyback yield (%): 0
Retained earnings: -70262448
Inventory turnover: 0.09570179171092628
Capitalized R&D asset: 461048.94
ROCI (R&D-adjusted, %): -9.33351074449181
FCF margin (%): -3731.3130748371586
Rule of 40 score: -3731.3130748371586
Financial ratios for PAVS — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -3995127
Buffett classification: The Gruesome
Stock price: 163200
Shares outstanding: 856851
Book value: 29002597
P/B ratio: 4821.5710889614475
Market cap (USD): 139838083200
Debt to equity: 0.08108198034817365
Current ratio: 1.1221548890955473
Quick ratio: 1.0201257596449433
Buyback yield (%): 0
Retained earnings: -70262448
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCRX.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -414100.7352941176
Net income: -380209.5588235294
Capital expenditures: 0
Operating cash flow: -88369.85294117646
Net tangible assets: 1997730.882352941
Owner earnings: -380209.5588235294
Return on net tangible assets (%): -19.032070945197383
Buffett classification: The Gruesome
Stock price: 0.4411764705882352
Shares outstanding: 196630859
Book value: 1997730.882352941
P/B ratio: 43.42372095693864
Market cap (USD): 86748908.38235293
Debt to equity: 0
Current ratio: 166.01147889462496
Quick ratio: 166.01147889462496
Free cash flow (dilution-adjusted): -372399.2647058823
Buyback yield (%): 0
Retained earnings: -399193.38235294115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.728554529145935
Rule of 40 score: 0
Financial ratios for PCRX.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -437848.4848484848
Net income: -356384.84848484845
Capital expenditures: 0
Operating cash flow: -393528.78787878784
Depreciation & amortization: 0
Net tangible assets: 1722974.2424242424
Owner earnings: -356384.84848484845
Return on net tangible assets (%): -20.684281848776294
Buffett classification: The Gruesome
Stock price: 0.1590909090909091
Shares outstanding: 196630859
Book value: 1722974.2424242422
P/B ratio: 18.15591977139601
Market cap (USD): 31282182.113636363
Debt to equity: 0
Current ratio: 50.24382375230053
Quick ratio: 50.24382375230053
Free cash flow (dilution-adjusted): -393528.78787878784
Buyback yield (%): 0
Retained earnings: -767675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.41236392671939
Rule of 40 score: 0
Financial ratios for PCRX.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 33092.59259259259
Buffett classification: The Gruesome
Stock price: 0.5111111111111111
Shares outstanding: 196630859
Market cap (USD): 100500216.82222222
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCRX.V — quarterly report dated 2024-12-31
Total revenue: 3076276.223776224
Gross profit: 1168023.7762237762
Operating income: 250466.43356643358
Net income: 505757.34265734267
Capital expenditures: 0
Operating cash flow: 779413.2867132868
Depreciation & amortization: 133960.13986013987
Net tangible assets: 9604072.727272728
Owner earnings: 639717.4825174825
Return on net tangible assets (%): 6.660897940733766
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.37762237762237766
P/E ratio: 36.703477254218214
Shares outstanding: 196630859
Book value: 21375009.79020979
P/B ratio: 3.4737861277387387
Market cap (USD): 74252212.48951049
Debt to equity: 0.031180683383484488
Current ratio: 8.592522107119969
Quick ratio: 7.81840354727967
Effective tax rate (%): -17.369276034034236
Interest coverage ratio: 24.879619338705194
COGS to revenue (%): 62.03124520495786
SG&A to revenue (%): 25.47226405551167
Free cash flow (dilution-adjusted): 1092861.5384615385
Buyback yield (%): 0
Retained earnings: -1416892.3076923077
Inventory turnover: 2.0782330151655817
Receivables turnover: 13.461762086767061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0687446664145646
FCF margin (%): 35.52546842233878
Rule of 40 score: 35.52546842233878
Financial ratios for PCRX.V — annual report dated 2024-12-31
Total revenue: 4052387.4125874126
Gross profit: 1527525.8741258741
Operating income: -1110722.3776223776
Net income: -734919.5804195805
Capital expenditures: 4818.181818181818
Operating cash flow: 87390.20979020979
Depreciation & amortization: 202709.0909090909
Net tangible assets: 9604072.727272728
Owner earnings: -537028.6713286713
Return on net tangible assets (%): -5.591676433308013
Buffett classification: The Gruesome
Stock price: 0.37762237762237766
Shares outstanding: 196630859
Book value: 21375009.79020979
P/B ratio: 3.4737861277387387
Market cap (USD): 74252212.48951049
Debt to equity: 0.031180683383484488
Current ratio: 8.592522107119969
Quick ratio: 7.81840354727967
Interest coverage ratio: -48.971233890361965
COGS to revenue (%): 62.30553205793908
SG&A to revenue (%): 60.10134058935128
Free cash flow (dilution-adjusted): -115437.76223776225
Buyback yield (%): 0
Retained earnings: -1416892.3076923077
Inventory turnover: 2.7497675240415553
Receivables turnover: 17.733217456232424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.739471872730443
FCF margin (%): -2.848635890023562
Rule of 40 score: -2.848635890023562
Financial ratios for PCRX.V — quarterly report dated 2025-03-31
Total revenue: 2802067.832167832
Gross profit: 1135674.8251748253
Operating income: 159556.64335664336
Net income: 177831.46853146853
Capital expenditures: 18813.286713286714
Operating cash flow: 90583.21678321679
Depreciation & amortization: 131090.2097902098
Net tangible assets: 9862992.307692308
Owner earnings: 290108.3916083916
Return on net tangible assets (%): 2.9413831275335314
Capex to operating income (%): 11.790976745001448
Buffett classification: The Great
Stock price: 0.3496503496503497
P/E ratio: 96.65337801171064
Shares outstanding: 196630859
Book value: 21552840.55944056
P/B ratio: 3.189929810494695
Market cap (USD): 68752048.6013986
Debt to equity: 0.02972405240371671
Current ratio: 8.582525051387462
Quick ratio: 7.652547923395977
Effective tax rate (%): 29.757284637418547
Interest coverage ratio: 16.647161826937108
COGS to revenue (%): 59.47011659970397
SG&A to revenue (%): 30.157298917857116
Free cash flow (dilution-adjusted): 71769.93006993008
Buyback yield (%): 0
Retained earnings: -1247723.076923077
Inventory turnover: 1.4695702743655195
Receivables turnover: 10.758751144488865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6771490235344054
FCF margin (%): 2.561320223800755
Revenue growth (%): -8.91364661889148
Rule of 40 score: -6.352326395090725
Financial ratios for PCRX.V — quarterly report dated 2025-06-30
Total revenue: 3208546.715328467
Gross profit: 1276236.4963503648
Operating income: -241373.7226277372
Net income: -280342.3357664233
Capital expenditures: 1546375.9124087591
Operating cash flow: -136369.34306569342
Depreciation & amortization: 137692.700729927
Net tangible assets: 7843799.270072992
Owner earnings: -1689025.5474452553
Return on net tangible assets (%): -21.53325817361894
Buffett classification: The Gruesome
Stock price: 0.3503649635036496
P/E ratio: 170.84480072656183
Shares outstanding: 196630859
Book value: 22215210.2189781
P/B ratio: 3.101143903575238
Market cap (USD): 68892563.73722626
Debt to equity: 0.02887805744193546
Current ratio: 5.583137124514226
Quick ratio: 4.792745114703941
Interest coverage ratio: -24.966553416383544
COGS to revenue (%): 60.22384557303497
SG&A to revenue (%): 43.00755577769137
Free cash flow (dilution-adjusted): -1682745.2554744524
Buyback yield (%): 0
Retained earnings: -1582709.4890510947
Inventory turnover: 1.5640542229963263
Receivables turnover: 6.83451784384363
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9951540551936403
FCF margin (%): -52.44571467310506
Revenue growth (%): 14.50638983447309
Rule of 40 score: -37.93932483863197
Financial ratios for PCRX.V — quarterly report dated 2025-09-30
Total revenue: 3454862.589928058
Gross profit: 1409323.7410071944
Operating income: -358860.4316546763
Net income: -294372.6618705036
Capital expenditures: 1494381.294964029
Operating cash flow: 395869.7841726619
Depreciation & amortization: 159950.35971223022
Net tangible assets: 5753036.690647483
Owner earnings: -1628803.5971223023
Return on net tangible assets (%): -28.31206690842409
Buffett classification: The Gruesome
Stock price: 0.3381294964028777
P/E ratio: 610.6766279409396
Shares outstanding: 196630859
Book value: 21735619.424460433
P/B ratio: 3.058881922459209
Market cap (USD): 66486693.330935255
Debt to equity: 0.14295074646394004
Current ratio: 2.5303164798984903
Quick ratio: 1.7935539192016978
Interest coverage ratio: -25.188910771095287
COGS to revenue (%): 59.20753128892048
SG&A to revenue (%): 46.54986330391593
Free cash flow (dilution-adjusted): 1890251.0791366908
Buyback yield (%): 0
Retained earnings: -1867503.5971223023
Inventory turnover: 1.1538196829946974
Receivables turnover: 6.110303997312731
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3716405851580822
FCF margin (%): 54.71277163518252
Revenue growth (%): 7.676867331332432
Rule of 40 score: 62.38963896651495